El-Kady Asmaa M, Abdel-Rahman Iman A M, Sayed Eman, Wakid Majed H, Alobaid Hussah M, Mohamed Khalil, Alshehri Eman Abdullah, Elshazly Hayam, Al-Megrin Wafa Abdullah I, Iqbal Furhan, Elshabrawy Hatem A, Timsah Ashraf G
Department of Medical Parasitology, Faculty of Medicine, South Valley University, Qena, Egypt.
Department of Pharmacognosy, Faculty of Pharmacy, South Valley University, Qena, Egypt.
Front Vet Sci. 2022 Aug 23;9:970327. doi: 10.3389/fvets.2022.970327. eCollection 2022.
Trichinellosis is a helminthic disease caused by the ingestion of raw or undercooked meat of infected animals. Current estimates indicate that 11 million humans have trichinellosis, worldwide. The effective use of anti-trichinella medications is limited by side effects and resistance which highlight the critical need for safe and effective drugs, particularly those derived from medicinal plants. Therefore, in the present study, we aimed to evaluate the efficacy of the ethanolic extract of () in treatment of experimentally induced trichinellosis.
Trichinellosis was induced experimentally in male 6-8 weeks BALB/c mice. BALB/c mice were divided into four groups, 10 mice each. One group was left uninfected and untreated, whereas three groups were infected with infected group of mice was left untreated (negative control) while the remaining two infected groups received either 300 mg/kg of the ethanolic extract of or 50 mg/kg of albendazole (positive control). All treatments started from the third day post-infection (dpi) for 3 successive days. All animals were sacrificed on the 7th dpi for evaluation of treatment efficacy.
Our findings showed that treatment reduced the adult-worm count in the intestine of infected animals. Moreover, treatment with restored the normal intestinal architecture, reduced edema, alleviated inflammation as demonstrated by reduced inflammatory infiltrate and expression of TGF-β in intestinal tissues of -treated animals compared to infected untreated animals.
Our findings show that extract is effective in treating experimentally induced trichinellosis which highlight the therapeutic potential of for intestinal trichinellosis.
旋毛虫病是一种因摄入受感染动物的生肉或未煮熟的肉而引起的蠕虫病。目前的估计表明,全球有1100万人感染旋毛虫病。抗旋毛虫药物的有效使用受到副作用和耐药性的限制,这突出表明迫切需要安全有效的药物,特别是那些源自药用植物的药物。因此,在本研究中,我们旨在评估()乙醇提取物对实验性诱导的旋毛虫病的治疗效果。
在6 - 8周龄的雄性BALB/c小鼠中实验性诱导旋毛虫病。将BALB/c小鼠分为四组,每组10只。一组未感染且未治疗,而三组感染了旋毛虫。感染组小鼠未接受治疗(阴性对照),而其余两组感染小鼠分别接受300 mg/kg的()乙醇提取物或50 mg/kg的阿苯达唑(阳性对照)。所有治疗从感染后第三天(dpi)开始,连续进行3天。所有动物在感染后第7天处死,以评估治疗效果。
我们的研究结果表明,()治疗降低了感染动物肠道内的成虫数量。此外,与未治疗的感染动物相比,()治疗恢复了正常的肠道结构,减轻了水肿,减轻了炎症,这通过()治疗动物肠道组织中炎症浸润减少和TGF-β表达降低得以证明。
我们的研究结果表明,()提取物对实验性诱导的旋毛虫病有效,这突出了()对肠道旋毛虫病的治疗潜力。